Our group has published extensively on the pro-tumorigenic role of the PDX1 transcription factor in pancreatic cancer progression [85,86,87,88,89,90,91], while other groups have demonstrated antimetastatic [92] and tumor-suppressive effects [93]. This evidence concerns the gene PDX1 and familial pancreatic carcinoma.